An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study (2021)

First Author: Surey J
Attributed to:  MRC Centre for Outbreak Analysis and Modelling Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12879-021-05766-9

Publication URI: http://dx.doi.org/10.1186/s12879-021-05766-9

Type: Journal Article/Review

Parent Publication: BMC Infectious Diseases

Issue: 1